Penn Pharma has completed the first phase of its $19.7 million expansion program with a $.5 million investment extending its facilities by 2,400m² and changing the transport and delivery infrastructure at its Tredegar headquarters.

Darren Hassey, chief operating officer at Penn Pharma, said, “The recent developments to the site only add to our established offerings. By altering the externals of the site and moving the delivery and collection points we have in turn altered the internal factory processes, ensuring the smooth flow of people, process and materials.”

Peter George, chief executive officer of Penn Pharma, said, “By heavily investing in our Tredegar site it strengthens our commitment to the local community and as a leading Welsh company we will endeavor to pay back the Assembly Government’s faith in us by driving sustainable growth and employment.”

Additional phases of the expansion will take place during the next five years.

News from our sister sites